PlusTherapeuticsInc . (NASDAQ:PSTV)’s share price rose 5.2% on Monday . The stock traded as high as $2.73 and last traded at $2.45, approximately 976,200 shares traded hands during mid-day trading. An increase of 366% from the average daily volume of 209,441 shares. The stock had previously closed at $2.33.
Separately, ValuEngine upgraded shares of PlusTherapeuticsInc . from a “hold” rating to a “buy” rating in a report on Tuesday, September 24th.
The company has a current ratio of 0.38, a quick ratio of 0.37 and a debt-to-equity ratio of 0.39. The company’s fifty day moving average is $7.71.
About PlusTherapeuticsInc . (NASDAQ:PSTV)
Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, engages in developing treatments for cancer and other diseases in the United States. The company's lead product candidate in pipeline is DocePLUS, an albumin-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer.
Featured Story: How to start trading in the forex market?
Receive News & Ratings for PlusTherapeuticsInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PlusTherapeuticsInc . and related companies with MarketBeat.com's FREE daily email newsletter.